Stallergenes Greer
Quick facts
Marketed products
Phase 3 pipeline
- Staloral · Other
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Stallergenes Greer
What are Stallergenes Greer's marketed drugs?
Top marketed products include 300 IR, Oralair.
What is Stallergenes Greer's pipeline?
Stallergenes Greer has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include Staloral.
Related
- 300 IR
- Oralair · Other
- Sector hub: All tracked pharma companies